DEXUS (ASX:DXS) Reviews Healthcare Fund Options, Does It Look Fully Valued?

Simply Wall St.01:28

DEXUS (ASX:DXS) has reportedly hired Denison Partners to review the Dexus Healthcare Property Fund, exploring asset sales, new capital structures or a potential wind-up to address liquidity pressures ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2677633977?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551734-choice2-card/1789011561490","is_english":true,"pubTime":"2026-10-24 01:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2677633977","market":"us","top_or_hot":-1,"title":"DEXUS (ASX:DXS) Reviews Healthcare Fund Options, Does It Look Fully Valued?","media":"Simply Wall St.","content":"<div>\n<p>DEXUS (ASX:DXS) has reportedly hired Denison Partners to review the Dexus Healthcare Property Fund, exploring asset sales, new capital structures or a potential wind-up to address liquidity pressures ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/real-estate/asx-dxs/dexus-shares/news/dexus-asxdxs-reviews-healthcare-fund-options-does-it-look-fu\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DEXUS (ASX:DXS) Reviews Healthcare Fund Options, Does It Look Fully Valued?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDEXUS (ASX:DXS) Reviews Healthcare Fund Options, Does It Look Fully Valued?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-24 01:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/real-estate/asx-dxs/dexus-shares/news/dexus-asxdxs-reviews-healthcare-fund-options-does-it-look-fu><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DEXUS (ASX:DXS) has reportedly hired Denison Partners to review the Dexus Healthcare Property Fund, exploring asset sales, new capital structures or a potential wind-up to address liquidity pressures ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/real-estate/asx-dxs/dexus-shares/news/dexus-asxdxs-reviews-healthcare-fund-options-does-it-look-fu\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XLV","symbol_name":"健康照护类股ETF-SPDR","start_time":0,"source_url":"https://simplywall.st/stocks/au/real-estate/asx-dxs/dexus-shares/news/dexus-asxdxs-reviews-healthcare-fund-options-does-it-look-fu","article_id":"2677633977","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551734-choice2-card/1789011561490"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/real-estate/asx-dxs/dexus-shares/news/dexus-asxdxs-reviews-healthcare-fund-options-does-it-look-fu","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2677633977","pubTimestamp":1792776528,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"DEXUS (ASX:DXS) has reportedly hired Denison Partners to review the Dexus Healthcare Property Fund, exploring asset sales, new capital structures or a potential wind-up to address liquidity pressures driven by redemptions.\nDEXUS shares trade at A$5.75, with a 1 month share price return of 3.42% and a 90 day gain of 1.95%. However, the year to date share price return is down 17.39% and the 1 year total shareholder return has fallen 20.29%, signalling that near term momentum has improved while...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"XLV":"健康照护类股ETF-SPDR","BK7154":"办公室房地产信托","HCSG":"Healthcare Svcs Group Inc","BK7122":"办公房地产投资信托","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","LABU":"三倍做多标普生物-Direxion","BK4581":"高盛持仓","BK4585":"ETF&股票定投概念","DXS.AU":"Dexus","BK7510":"REITs概念","BK4137":"综合支持服务","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","BK4588":"碎股","XBI":"SPDR S&P Biotech ETF"},"translate_title":"DEXUS (ASX:DXS) 审查医疗保健基金期权，它看起来完全有价值吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":0.6,"XBI":0.6,"XLV":1.5,"DXS.AU":1,"HCSG":1.5},"content_text":"DEXUS (ASX:DXS) has reportedly hired Denison Partners to review the Dexus Healthcare Property Fund, exploring asset sales, new capital structures or a potential wind-up to address liquidity pressures driven by redemptions. DEXUS shares trade at A$5.75, with a 1 month share price return of 3.42% and a 90 day gain of 1.95%. However, the year to date share price return is down 17.39% and the 1 year total shareholder return has fallen 20.29%, signalling that near term momentum has improved while longer term performance remains weak. Compare how DEXUS’s repositioning efforts stack up against other real estate groups under pressure by scanning our curated list of solid balance sheet and fundamentals (12 results) for potential alternatives. DEXUS trades at a clear discount to both analyst targets and an internal value estimate, yet the share price has started to recover. Where does that put fair value now that this healthcare fund review is part of the picture? AdvertisementMost Popular Narrative: 1% Overvalued DEXUS closed at A$5.75 against a widely followed fair value of A$5.70, a small premium that reflects a cautious outlook built into a relatively high discount rate of 8.66%.  Although access to diverse equity capital and the push to bring partners into the A$13b investment portfolio can release capital, moving from balance sheet ownership to lower co investment stakes rebalances the business toward fee based income. This may moderate absolute rental revenue even as funds management earnings become a larger share of the total.  See why 0 investors see DEXUS as 1% overvalued. Result: Fair Value of A$5.70 (OVERVALUED) Still, a successful resolution of the APAC legal appeals or stronger fee income from the A$36b funds platform could quickly challenge this cautious DEXUS narrative. Find out about the key risks to this DEXUS narrative. Another View On DEXUS Valuation The earlier narrative framed DEXUS as slightly overvalued on a fair value of A$5.70. Using a simple earnings multiple tells a different story. DEXUS trades on a P/E of 10.1x versus 17.4x for the global Office REITs sector and a fair ratio of 10.7x, which implies a more modest pricing gap that could matter if sentiment swings. To see how this earnings multiple stacks up against peers and what that gap could mean for future valuation risk or opportunity, See what the numbers say about this price — find out in our valuation breakdown.. ASX:DXS P/E Ratio as at Oct 2026Next Steps Mixed signals on DEXUS so far. If you want to move quickly and form your own view using the underlying data and context, review the 2 key rewards and 2 important warning signs. Looking for more DEXUS sized investment ideas? If DEXUS has you rethinking your portfolio balance, now is the time to scan fresh opportunities before the next wave of investors moves first.  Target quality at a discount by reviewing the 4 high quality undervalued stocks that combine solid finances with prices that lag underlying fundamentals. Strengthen your income stream by assessing the 6 dividend fortresses that aim to pair higher yields with more resilient payouts. Dial back portfolio risk by focusing on the 6 resilient stocks with low risk scores that score well on financial resilience and volatility control.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2677633977","isCrawlerRequest":true}